AMBRA1 attenuates the proliferation of uveal melanoma cells

Abstract Uveal melanoma (UVM) is the most common primary intraocular malignancy in adults with high metastasis rates. D-type cyclins (CCNDs) are central regulators of the cell division cycle and are among the most frequently deregulated therapeutic targets in human cancer. Recently, the E3 ligase adaptor, autophagy and beclin 1 regulator 1 (AMBRA1), was reported to regulate the stability of CCNDs, including CCND1, but its role in UVM has not been demonstrated. AMBRA1 is lowly expressed in UVM cells, and the ablation of AMBRA1 promotes the proliferation of 92.1 and OMM1 cells, whereas ectopically expressing AMBRA1 attenuates the proliferation of UVM cells. Further studies found that AMBRA1 promotes the ubiquitination and degradation of CCND1, and AMBRA1 regulates the proliferation of UVM cells in a CCND1-dependent manner. Thus, this study suggests that AMBRA1 serves as an important tumor suppressor by limiting UVM cell growth.

[1]  Wenli Lu,et al.  Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes , 2021, Frontiers in Genetics.

[2]  Colin J. Daniel,et al.  Loss of Ambra1 promotes melanoma growth and invasion , 2021, Nature Communications.

[3]  D. Petrov,et al.  The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D , 2021, Nature.

[4]  Colin J. Daniel,et al.  AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity , 2021, Nature.

[5]  M. Pagano,et al.  CRL4AMBRA1 is a master regulator of D-type cyclins , 2021, Nature.

[6]  Xiaoxu Tian,et al.  MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty , 2021, Nucleic acids research.

[7]  Xianqun Fan,et al.  Uveal melanoma: progress in molecular biology and therapeutics , 2020, Therapeutic advances in medical oncology.

[8]  M. Kimura,et al.  AMBRA1 controls antigen-driven activation and proliferation of naïve T cells. , 2020, International immunology.

[9]  Chao Peng,et al.  An Integrative Synthetic Biology Approach to Interrogating Cellular Ubiquitin and Ufm Signaling , 2020, International journal of molecular sciences.

[10]  G. Schwartz,et al.  Metastatic disease from uveal melanoma: treatment options and future prospects , 2016, British Journal of Ophthalmology.

[11]  David Komander,et al.  Ubiquitin modifications , 2016, Cell Research.

[12]  J. Morrow,et al.  Targeting ubiquitination for cancer therapies. , 2015, Future medicinal chemistry.

[13]  Ivan Dikic,et al.  Ubiquitination in disease pathogenesis and treatment , 2014, Nature Medicine.

[14]  T. Aytekin,et al.  A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[15]  H. Ji,et al.  Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression. , 2014, Cancer cell.

[16]  S. Ge,et al.  Detection and Validation of Circulating Endothelial Cells, a Blood-based Diagnostic Marker of Acute Myocardial Infarction , 2013, PloS one.

[17]  Sanket U. Shah,et al.  Iris melanoma: features and prognosis in 317 children and adults. , 2012, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[18]  J. O'Brien,et al.  Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.

[19]  Wen-li Ma,et al.  FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma. , 2010, Oncology reports.

[20]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[21]  P. Sorensen,et al.  The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers , 2007, Nature Medicine.

[22]  N. Laperriere,et al.  Management of single brain metastasis: a practice guideline , 2007, Current oncology.

[23]  J. Alao,et al.  Molecular Cancer BioMed Central Review The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention , 2007 .

[24]  A. Klein-Szanto,et al.  Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex , 2006 .

[25]  A. Klein-Szanto,et al.  Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. , 2006, Molecular cell.

[26]  D. Germain,et al.  A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT , 2001, Oncogene.

[27]  S. Legha,et al.  Uveal melanoma: natural history and treatment options for metastatic disease. , 1999, Melanoma research.